Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERAMIQUE trial: Eldecalcitol plus risedronate for AI-induced secondary osteoporosis in postoperative breast cancer
jRCTs051180179Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of eldecalcitol in secondary osteoporosis and breast cancer (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Lumbar spine bone mineral density change. Started Oct 2012; status: completed.
02
Drugs
eldecalcitol
03
Conditions
secondary osteoporosisbreast cancer
Beyond the preview
Go deeper on jRCTs051180179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180179.